Print Friendly, PDF & Email

Last week, the FDA approved the drug Latisse for “hypotrichosis of the eyelashes” according to the Wall Street Journal Health Blog. What’s that? It’s “another name for having inadequate or not enough eyelashes.” Honest. The company that makes Latisse also makes another critical health care treatment, Botox.
Happy New Year everyone from the CT Health Policy Project.